Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 17 , ISSUE 4 ( August, 2013 ) > List of Articles

LETTER TO EDITOR

Metabolic alkalosis: A less appreciated side effect of Imipenem-cilastatin use

Pragyan Swagatika Panda, Surya Kumar Dube, Suman Sarkar, Dinesh Kumar Singh

Citation Information : Panda PS, Dube SK, Sarkar S, Singh DK. Metabolic alkalosis: A less appreciated side effect of Imipenem-cilastatin use. Indian J Crit Care Med 2013; 17 (4):263-264.

DOI: 10.4103/0972-5229.118411

License: CC BY-ND 3.0

Published Online: 01-08-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Edwards SJ, Emmas CE, Campbell HE. Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections. Curr Med Res Opin 2005;21:785-94.
  2. Galla JH. Metabolic alkalosis. J Am Soc Nephrol 2000;11:369-75.
  3. Brunner FP, Frick PG. Hypokalemia, metabolic alkalosis and hypernatremia due to massive sodium penicillin therapy. Br Med J 1968;30:550-2.
  4. Bhagwat A, Goel N, Sharma R, Jain S, Dua K. Meropenem: A unusual cause of metabolic alkalosis in critical care patients. Anaesth Intensive Care 2008;36:745-6.
  5. Zaki SA, Shanbag P. Meropenem induced hypokalemia and metabolic alkalosis. Indian J Pharmacol 2012;44:276-7.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.